Dr. Lentzsch has a high interest in clinical research and is the principal investigator of many phase 1, 2 and 3 clinical trials, including investigator-initiated studies for newly diagnosed and relapsed/refractory multiple myeloma, for maintenance following transplant for multiple myeloma and amyloidosis. Her translational laboratory research focuses on the identification of novel targets for the treatment of MM, MM bone disease and amyloidosis and is funded by multiple awards from the NIH, the Pennsylvania Department of Health, the German Cancer Foundation, the Leukemia and Lymphoma Society, the Multiple Myeloma Research Foundation and the International Myeloma Society. She is a member of the NCI Myeloma Steering Committee and has published over 80 original articles, editorials, chapters, many as the lead or senior author, in such prestigious journals as Journal of Clinical Investigations, Blood, Cancer Research, and Leukemia.

Get the latest thought leadership on Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.

Thanks to our HealthTree Community for Myeloma Sponsors:

Genentech
Abbvie
Bristol Myers Squibb
Janssen Oncology
GSK

Follow Us

facebook instagram twitter youtube

Copyright © 2022 HealthTree Foundation. All Rights Reserved.

The HealthTree Foundation / Myeloma Crowd is a qualified 501(c)(3) tax-exempt organization. Tax ID 45-5354811

 https://www.guidestar.org/profile/45-5354811